Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings. - Tartour, E; Mehtali, M; Sastre-Garau, X; Joyeux, I; Mathiot, C; Pleau, J M; Squiban, P; Rochlitz, C; Courtney, M; Jantscheff, P; Herrmann, R; Pouillart, P; et al. (British Journal of Cancer, 2000)